title: Development of cowpea mosaic virus-based vectors for the production of vaccines in plants.
abstract: Plant viruses are emerging as an attractive alternative to stable genetic transformation for the expression of foreign proteins in plants. The main advantages of using this strategy are that viral genomes are small and easy to manipulate, infection of plants with modified viruses is simpler and quicker than the regeneration of stably transformed plants and the sequence inserted into a virus vector will be highly amplified. One use of these virus expression systems is for vaccine production. Among plant viruses, cowpea mosaic virus makes an ideal candidate for the production of such vaccines because it grows extremely well in host plants, is very stable, and the purification of virus particles, if required, is straightforward. In this article, the authors review the progress made in the development of cowpea mosaic virus-based vectors for vaccine production, making use of two main approaches: epitope presentation and polypeptide expression.
authors.affiliation: Department of Biological Chemistry, John Innes Centre, Norwich, NR4 7UH, UK. carmen.canizares@eelm.csic.es
authors.forename: M Carmen
authors.initials: MC
authors.lastname: Cañizares
authors.forename: George P
authors.initials: GP
authors.lastname: Lomonossoff
authors.forename: Liz
authors.initials: L
authors.lastname: Nicholson
mesh_terms: D000818:Animals; D017798:Comovirus / Q000235:genetics*; D000939:Epitopes / Q000096:biosynthesis* / Q000235:genetics / Q000276:immunology; D005822:Genetic Vectors; D015700:HIV Envelope Protein gp41 / Q000096:biosynthesis / Q000235:genetics / Q000276:immunology; D006512:Hepatitis B Core Antigens / Q000096:biosynthesis / Q000235:genetics / Q000276:immunology; D006801:Humans; D011994:Recombinant Proteins / Q000096:biosynthesis* / Q000235:genetics / Q000276:immunology; D012229:Rhinovirus / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D014614:Vaccines, Synthetic / Q000096:biosynthesis*
chemical_list: D000939:Epitopes; D015700:HIV Envelope Protein gp41; D006512:Hepatitis B Core Antigens; D011994:Recombinant Proteins; D014614:Vaccines, Synthetic